Manufacturing

Eywa has established a state-of-the-art oral solid dosage manufacturing facility in Cranbury, New Jersey, USA . This facility manufactures tablets, capsules and oral suspensions.

Our team possess extensive experience in commercial manufacturing of high quality generic pharmaceuticals in a cGMP compliant environment, including successful technology transfers.



Development

Eywa has established a state- of- the- art facility for development of Solid Oral Dosage forms at Ticel Bio Park, Chennai, India. This facility has pilot scale manufacturing capabilities.

Our team of highly experienced scientists develop generic medicines based on robust technologies, covering a variety of therapeutic areas and dosage forms, including tablets, capsules and oral suspensions.



Quality

At Eywa, Quality is a way of life. Our highest priority is Quality by Design (QbD) in everything that we do. With the objective of continuous improvement, we challenge and constantly train ourselves as a team. Our systems, protocols and procedures have been designed to facilitate such constant training, monitoring and review.

We believe in setting and exceeding high quality standards and expect the same of our partners and suppliers. Therefore, we continuously ensure that quality systems across our partners’ and our development and manufacturing facilities, meet and exceed the standards set forth by the regulatory bodies around the world.